Strategies for transporting nanoparticles across the blood–brain barrier
The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Nanoparticles have been widely deployed for brain-targeted delivery. Drugs can be embedded either in a matrix or deposited on the surface of nanoparticles, and the whole particle can cross the BBB effectively and be targeted to specific parts of the body in a controllable manner.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,805
Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
Maeda, H. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100070g · Cited by 998
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
Madani, F., Lindberg, S., Langel, Ü., Futaki, S., & Gräslund, A. (2011) · Journal of Biophysics · doi:10.1155/2011/414729 · Cited by 984
Nanoparticulate systems for brain delivery of drugs
Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958
Cell‐penetrating peptides: 20 years later, where do we stand?
Bechara, C., & Sagan, S. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.04.031 · Cited by 857
Cell-penetrating peptides: classes, origin, and current landscape
Milletti, F. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.002 · Cited by 813
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Gabathuler, R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 802
Research works printed but not linked: 8
- Weidle, 2015, Cancer Genomics Proteomics, 12, 167
- Schmid-Brunclik, 2008, Am. J. Physiol.: Regul., Integr. Comp. Physiol., 295, R864
- Hagg, 2006, J. Neurotrauma, 23, 264
- Kozler, 2012, Neuroendocrinol. Lett., 33, 782
- Piraux, 2015, J. Appl. Phys., 117
- Zheng, 2015, Int. J. Clin. Exp. Med., 8, 1658
- Nounou, 2014, Cancer Res., 74
- Maletinska, 2000, Cancer Res., 60, 2300
Cited by
Items 201–300 of 310
Advances in the study of polydopamine nanotechnology in central nervous system disorders
Ren, S., Xiao, X., Lv, J., Lv, S., Wang, X. T., Liu, R., & Kong, Q.-X. (2024) · Frontiers in Materials · doi:10.3389/fmats.2024.1396397 · Cited by 12
Nikfar, B., Musavi, M., Chaichian, S., Guo, G., & Momtazi‐Borojeni, A. A. (2025) · Nanoscale · doi:10.1039/d5nr02445e · Cited by 12
Fu, M., Tian, Y., Zhang, T., Zhan, Q., Zhang, L., & Wang, J. (2020) · Food & Function · doi:10.1039/d0fo01563f · Cited by 12
Self-citationDing, S., Xiong, J., Lei, D., Zhu, X., & Zhang, H. (2018) · Journal of Cancer · doi:10.7150/jca.22163 · Cited by 12
“2 h after injection, the fluorescence signals of NIR-797 labelled Taxol® was weak and mainly localized in the liver area, but it began to appear in the tumor site at 4-8 h and decreased gradually especially in the tumor site with no distribution in the brain [24].”
BackgroundMagro, R. D., Cox, A., Zambelli, V., Mancini, S., Masserini, M., & Re, F. (2018) · Nanomedicine · doi:10.2217/nnm-2017-0317 · Cited by 14
Liposome-Based Drug Delivery for Brain Tumor Theranostics
Xin, H., Jiang, Y., Lv, W., & Xu, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812218-1.00009-9 · Cited by 13
Nanoparticles drug-delivery systems and antiangiogenic approaches in the treatment of gliomas
Caffo, M., Cardali, S., Fazzari, E., Barresi, V., & Caruso, G. (2018) · Glioma · doi:10.4103/glioma.glioma_43_18 · Cited by 12
“Receptor-mediated transcytosis has been demonstrated for transferrin, insulin, insulin-like growth factors (IGF-1 and IGF-2), and the low-density lipoprotein receptor-related protein (LRP).[17] Transferrin receptor (TR) is a transmembrane glycoprotein overexpressed in GBM cells.”
BackgroundOnyema, H. N., Berger, M., Musyanovych, A., Bantz, C., Maskos, M., & Freese, C. (2021) · Biointerphases · doi:10.1116/6.0000889 · Cited by 13
Razavi, M. S., Ahmadi, F., Ebrahimnejad, P., Akbarzadeh, A., Farokhrou, M., & Nokhodchi, A. (2024) · Pharmaceutical Sciences · doi:10.34172/ps.2023.27 · Cited by 17
Herbal nanoparticles: a targeted approach for neurodegenerative disorder treatment
Panda, P., & Mohapatra, R. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2391913 · Cited by 13
Advances in Antibody-Based Therapeutics for Cerebral Ischemia
Sun, J., Yen, T., Jan, J., Mwale, P. F., Teng, R.-D., Taliyan, R., Hsieh, C.-T., & Yang, C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010145 · Cited by 12
Shi, H., Wang, B., Shi, Z., Ma, H., Li, Y., Liu, Y., Zhao, Y., Xia, N. L., Wu, C., & Gao, Y. J. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107783 · Cited by 12
Bechinger, P., Serrano, L. E., Grützner, V., Musyanovych, A., Jussen, D., Krenzlin, H., Eldahaby, D., Riede, N., Kempski, O. S., Ringel, F. A., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.994877 · Cited by 10
Hegde, M. M., Sandbhor, P., Aishwarya, J., Gota, V., & Goda, J. S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1168454 · Cited by 11
“Therefore, these ligands might act as a conduit for NPs to cross the BBB (51, 52).”
BackgroundGuo, C., Valdés, A., Sánchez-Martínez, J. D., Ibáñez, E., Bi, J., & Cifuentes, A. (2022) · Foods · doi:10.3390/foods11162464 · Cited by 11
“The BBB permeability has been taken as a crucial factor in neuroprotective drug discovery [50] and an artificial BBB method has been optimized and successfully applied to screen compounds from natural products that can penetrate the brain [51].”
MethodTargeting the undruggable in glioblastoma using nano-based intracellular drug delivery
Shirvalilou, S., Khoei, S., Afzalipour, R., Ghaznavi, H., Shirvaliloo, M., Derakhti, Z., & Sheervalilou, R. (2024) · Medical Oncology · doi:10.1007/s12032-024-02546-8 · Cited by 10
“RMT contains a variety of specific peptide receptors such as lactoferrin receptor (LfR), low-density lipoprotein receptor (LDLR), transferrin receptors (TfRs),, insulin receptor (IR), and insulin-like growth factor receptors (IGFR) [119], which will be discussed later.”
Habumugisha, T., Zhang, Z., Ndayishimiye, J. C., Nkinahamira, F., Uwizewe, C., Cyubahiro, E., Rehman, A., Yan, C., & Zhang, X. (2023) · Environmental Science Nano · doi:10.1039/d3en00017f · Cited by 12
Bioinspired Approaches for Central Nervous System Targeted Gene Delivery
Kumar, J., Karim, A., Sweety, U. H., Sarma, H., Nurunnabi, M., & Narayan, M. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00842 · Cited by 11
Research progress on antioxidant activity of natural products
Chen, L., Zhang, X., Hao, T., Liang, R., Man, S.-Y. B., Huang, G., & Tang, S. (2016) · European Journal of BioMedical Research · doi:10.18088/ejbmr.2.1.2016.pp36-40 · Cited by 24
Xie, K., Song, S., Zhou, L., Wan, J., Qiao, Y., Wang, M., Xie, H., Zhou, L., Zheng, S., & Wang, H. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.12.017 · Cited by 9
Neural Regenerative Nanomedicine
(2020) · Elsevier eBooks · doi:10.1016/c2019-0-01415-x · Cited by 10
Karmakar, V., Lim, W., & Gorain, B. (2025) · Biomaterials Science · doi:10.1039/d5bm00066a · Cited by 8
Lipid and polymeric nanocarriers for siRNA delivery to the brain
Koirala, S., & Cheng, K. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114286 · Cited by 9
Modulatory Effects of Natural Products on Neuronal Differentiation
An, J., Chen, B., Wang, A., Hao, D., Zhang, Q., Zhao, J., Liu, C., Zhang, L., Zhang, R., & Yang, H. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000496 · Cited by 8
Functional nanoassemblies for the diagnosis and therapy of Alzheimer's diseases
Zhang, L., Sun, H., Chen, Y., Wei, M., Lee, J., Li, F., & Ling, D. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1696 · Cited by 9
Aw, M. S., & Paniwnyk, L. (2017) · Biomaterials Science · doi:10.1039/c7bm00425g · Cited by 9
Biodegradable Polymeric Nanoparticles for Brain-Targeted Drug Delivery
Kempe, K., & Nicolazzo, J. A. (2020) · Neuromethods · doi:10.1007/978-1-0716-0838-8_1 · Cited by 10
Oliveira, J. W. D. F., Alves-Silva, M. F., Damasceno, I. Z., Rocha, H. A. O., da Silva-Júnior, A. A., & Silva, M. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030497 · Cited by 9
The Strategies of Nanomaterials for Traversing Blood-Brain Barrier
Rauf, M. A., Rehman, F. U., Zheng, M., & Shi, B. (2019) · Springer eBooks · doi:10.1007/978-981-13-8731-9_2 · Cited by 9
Wu, Y., Sun, C., Jin, K., & Dong, C. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s517928 · Cited by 9
Pinna, A., Ragaisyte, I., Morton, W., Angioletti‐Uberti, S., Proust, A. M., D’Antuono, R., Luk, C. H., Gutierrez, M. G., Cerrone, M., Wilkinson, K. A., et al. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c06726 · Cited by 8
Potential Application of Upconverting Nanoparticles for Brain Photobiomodulation
Meynaghizadeh-Zargar, R., Salehpour, F., Hamblin, M. R., Mahmoudi, J., & Sadigh‐Eteghad, S. (2019) · Photobiomodulation Photomedicine and Laser Surgery · doi:10.1089/photob.2019.4659 · Cited by 8
Hybrid nanoparticles to cross the blood–brain barrier
Desai, H. R., & Shinde, U. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90773-6.00002-6 · Cited by 8
Rathnam, S. S., Deepak, T., Sahoo, B. N., Meena, T., Singh, Y., & Joshi, A. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001689 · Cited by 7
The Significance of Nanomedicine in Brain-Targeted Drug Delivery: Crossing Blood-Brain Barriers
Singh, D. (2017) · Journal of Nanomedicine Research · doi:10.15406/jnmr.2017.05.00132 · Cited by 7
“It is now well established that vasculature within brain capillaries are made of a unique barricade, coined blood brain barrier (BBB) which segregates the brain from harmful substances while impeding the systemic delivery of pharmaceuticals from the blood into the brain [7].”
BackgroundModified biopolymer-based systems for drug delivery to the brain
Thakur, A., Sidu, R. K., Gaurav, I., Kumari, S., Chakraborty, P., & Thakur, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821437-4.00016-5 · Cited by 8
The Role of Nanotechnologies in Brain Tumors
Caffo, M., Caruso, G., Curcio, A., Laera, R., Crisafulli, C., Fazzari, E., Passalacqua, M., & Germanò, A. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-14732-6_11 · Cited by 8
Brain microvascular endothelial cell metabolism and its ties to barrier function
Weber, C. M., Moiz, B., & Clyne, A. M. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2024.05.002 · Cited by 9
Bayoumi, M., Youshia, J., Arafa, M. G., Nasr, M., & Sammour, O. A. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202400343 · Cited by 7
Pragya, Bisht, S., & Parashar, P. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02929-0 · Cited by 7
Almehdi, A. M., Baker, D. H. A., Hamdy, R., & El‐Keblawy, A. A. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.101906 · Cited by 7
Protein-Based Drug Delivery in Brain Tumor Therapy
Hwang, H. H., & Lee, D. Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3258-0_13 · Cited by 6
Zinc Oxide Nanoparticles: Future Therapy for Cerebral Ischemia
Basuthakur, P., & Patra, C. R. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0322 · Cited by 6
Targeted drug delivery: concepts, approaches, and applications
Russi, M., Marson, D., Laurini, E., & Pricl, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91816-9.00003-5 · Cited by 10
Mishra, M. A., Sahu, P. K., Satapathy, B. S., & Biswal, B. (2024) · Current Nanomaterials · doi:10.2174/0124054615322050240817172547 · Cited by 5
Evaluation of the effect of guanabenz-loaded nanoparticles on chronic toxoplasmosis in mice
ELGENDY, W. M. A., Haggag, Y. A., El-Nouby, K. A., El-Kowrany, S. I., & Elmarhoumy, S. M. (2023) · Experimental Parasitology · doi:10.1016/j.exppara.2023.108460 · Cited by 5
Recent advances in nanotechnology and its application for neuro-disease: a review
Radhakrishnan, K. G., Kumar, P. S., Rangasamy, G., Ankitha, K., Niyathi, V., Manivasagan, V., & Saranya, K. (2023) · Applied Nanoscience · doi:10.1007/s13204-023-02958-4 · Cited by 6
“The main protein that aids in the forming of the junction is claudins and their main function is producing transepithelial electrical resistance (TEER) (Zhang et al. 2016b).”
BackgroundTarannum, S., & Jain, K. (2023) · Springer eBooks · doi:10.1007/978-981-99-6807-7_16 · Cited by 5
Nahhas, A. F., Nahhas, A. F., & Webster, T. J. (2024) · OpenNano · doi:10.1016/j.onano.2024.100209 · Cited by 5
Iron oxide nanoparticles: current and future applications in nanomedicine
Ezealigo, B. N., Ezealigo, U. S., Ighodalo, K. I., & Ezema, F. I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822819-7.00011-9 · Cited by 5
Multifaceted Therapy of Nanocatalysts in Neurological Diseases
Wang, H., Chen, X., Mao, M., & Xue, X. (2021) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2021.3063 · Cited by 5
Alzheimer’s disease: unraveling role of xanthone derivatives and nanocarriers
Suhaili, I. N. A., Yow, H.-Y., Mah, S. H., Huri, H. Z., & Tan, S. L. J. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04446-8 · Cited by 4
Meyer, Z. A., & Rambharose, S. (2025) · BioMetals · doi:10.1007/s10534-025-00757-8 · Cited by 4
“Surface modification, such as capping the surface, or conjugation with specific antibodies and surfactants, further enhances NP’s ability to overcome treatment challenges such as the BBB permeability (Zhang et al. 2016; Ceña and Játiva 2018).”
Biomedical applications of nanocarriers in brain tumor targeting
Dighe, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90773-6.00011-7 · Cited by 4
In-situ Gels for Brain Delivery: Breaching the Barriers
Fatima, G. N., Maurya, P., Nishtha, & Saraf, S. K. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230803114513 · Cited by 4
Nose to brain drug delivery through advanced drug delivery systems
Kumar, R., Singh, A., Kapoor, B., Hussain, M. S., Singh, S. K., Dua, K., Dureja, H., Thomas, N. V., & Gulati, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13474-6.00001-9 · Cited by 7
Forouzanfar, F., Ahmadzadeh, A. M., Pourbagher‐Shahri, A. M., & Gorji, A. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177690 · Cited by 4
Ahmad, H., Arya, A. K., Agrawal, S., & Dwivedi, A. K. (2020) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-030-44925-4_1 · Cited by 5
Liu, X., Chen, R., Wu, F., Yu, B., Zhou, G., Hu, S., Zhang, H., Wang, P., Xu, B., & Zhuang, L. (2026) · Sensors · doi:10.3390/s26082523 · Cited by 4
“Almost all macromolecular drugs and more than 98% of small-molecule drugs cannot cross the BBB, with only molecules under 400 Da or those with high lipid solubility able to pass through via passive diffusion [4,5].”
Self-citationLi, S., Ren, Y., Xiao, X. R., Chen, Y., Zhao, W. D., Liu, H., Ding, Z., Xu, Y., Xin, H., & Guo, Y. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.166832 · Cited by 4
Chakraverty, R., Samui, S. N., & Debnath, T. (2025) · Journal of Medical Evidence · doi:10.4103/jme.jme_155_23 · Cited by 3
Recent development in arsenic speciation and toxicity reduction of inorganic arsenic in food
Chen, L., Liang, R., Tan, T., Ai, X., Hao, T., Chen, X., & Wang, Y. (2016) · European Journal of BioMedical Research · doi:10.18088/ejbmr.2.1.2016.pp27-31 · Cited by 3
The role of blood–brain and blood–retinal barriers in drug delivery
Bonilla-Vidal, L., Esteruelas, G., Souto, E. B., Espina, M., García, M. L., & López, E. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90471-1.00002-5 · Cited by 3
Advanced Polymeric Nanoparticles for the Treatment of Neurodegenerative Diseases
Ferrão, R., & Rai, A. (2024) · Wiley eBooks · doi:10.1002/9783527837021.ch27 · Cited by 3
Li, J., Basu, K., Chen, X., & Li, T. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c01196 · Cited by 2
Sonmez, C., Baltacioglu, A., Coşkun, J., Demirbolat, G. M., Gök, Ö., & Özpınar, A. (2026) · Life · doi:10.3390/life16010131 · Cited by 2
“…owing to their appropriate size, high stability, biodegradability, excellent biocompatibility, capacity for selective drug delivery, enhanced bioavailability with reduced side effects, low toxicity, and an ability to circumvent the liver, thereby avoiding first-pass metabolism [26–28].”
Alansari, W. S., El‐Shetry, E. S., Alotaibi, B. S., Abd‐Elhakim, Y. M., Mohamed, A. A.-R., Said, E. N., Noreldin, A. E., Khamis, T., Alsubaie, N., & Saleh, A. A. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05664-8 · Cited by 2
“…taurine derivatives, nanoparticle-based delivery systems, intranasal administration, or other approaches to enhance brain bioavailability [73, 74], may help clarify the extent to which Tau’s neuroprotective effects are driven by direct CNS penetration versus indirect systemic mechanisms [75].”
BBB-aware stimuli-responsive and biomimetic nanomedicines for glioblastoma
Javaid, S., Song, W., Ali, S., Hou, W., Su, X., Wang, H., & Song, Y. (2026) · Chinese Neurosurgical Journal · doi:10.1186/s41016-026-00438-6 · Cited by 4
“However, this effect is highly variable in brain tumors: infiltrative margins often retain an intact BBB, whereas necrotic cores are more permeable, leading to non-uniform NP distribution and residual tumor cell survival [70, 71].”
Liposome-based targeted delivery of anticancer drugs for effective therapy of brain tumors
Shah, M. R., Imran, M. A., & Ullah, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816773-1.00003-1 · Cited by 2
Bhunia, S., & Chaudhuri, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101925 · Cited by 4
Nanotechnology in Drug Delivery: An Overview of Developing the Blood Brain Barrier
Dash, R., Samanta, S., Jena, B. R., & Pradhan, S. (2024) · Current Neurovascular Research · doi:10.2174/0115672026346307240919112023 · Cited by 2
Haiss, M. A., & Alhammid, S. N. A. (2025) · Pharmaceutical Nanotechnology · doi:10.2174/0122117385392040250404114249 · Cited by 4
Targeting the Blood-Brain Barrier with Nano-Biomaterials
Gowda, S. K., Venkataramanamma, D., & Singh, R. (2024) · Springer eBooks · doi:10.1007/978-981-97-3925-7_3 · Cited by 2
Yan, C., Zhu, X., Ren, Y., Guan, S., He, S., Qiu, F., Huang, M., Qu, X., & Liu, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143645 · Cited by 5
Ansari, S. A., Ficiarà, E., D’Agata, F., Cavalli, R., Nasi, L., Casoli, F., Albertini, F., & Guiot, C. (2021) · Molecules · doi:10.3390/molecules26154591 · Cited by 3
“In addition to chemical ones, physical targeting methods have also been investigated in the past [17].”
BackgroundNanotherapeutics of Phytoantioxidants for CNS Disorders
Paul, A., Guha, N., & Zaman, K. (2022) · Wiley eBooks · doi:10.1002/9781119811794.ch20 · Cited by 2
Unlocking Dendrimers Future Potential for Brain-Specific Drug Delivery in Cerebroanoreach
Jain, A., Yadav, S., & Khan, J. (2024) · Recent Advances in Drug Delivery and Formulation · doi:10.2174/0126673878303735240906065735 · Cited by 2
Lehrich, B. M., Liang, Y., & Fiandaca, M. S. (2024) · Springer eBooks · doi:10.1007/978-3-030-80662-0_4 · Cited by 1
Rational Design and Applications of Ultrasmall Gold Nanoparticles
Parambath, J. B. M., Arooj, M., Anand, K. V., Kanan, S., & Mohamed, A. A. M. (2025) · Topics in Current Chemistry · doi:10.1007/s41061-025-00520-0 · Cited by 1
Yadav, A., Kumar, S., Parveen, S., Kesharwani, P., & Shukla, R. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.116220 · Cited by 1
Haiss, M. A., & Alhammid, S. N. A. (2025) · OpenNano · doi:10.1016/j.onano.2025.100265 · Cited by 1
Nanomedicines for neurological disorders: Recent advances
Tamboli, Q. Y., Debasmita, D., Umair, M., Bushnak, I., Panda, J., Nayak, D., & Mohanta, Y. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26761-1.00010-7 · Cited by 1
Singh, M. P., Chettupalli, A. K., Bukke, S. P. N., Mugaiahgari, B. K. M., Uppu, P., Pathak, P., & Narapureddy, B. R. (2026) · BioMedical Engineering OnLine · doi:10.1186/s12938-026-01582-x · Cited by 2
“Table 2 describes some mechanism of transport of nanoparticles through BBB [113, 122, 128].”
Nanotoxicity in neural regenerative medicine
Çakır-Koç, R., Çalık, H., Mutlu, B., Ay, H. F., Karavelioğlu, Z., Aslan-Polat, B., & Pençeci, B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820223-4.00008-5 · Cited by 1
Polymeric Nanoparticles to Target Glioblastoma Tumors
Patil, P. H., Pardeshi, C. V., & Surana, S. J. (2022) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-031-14848-4_12 · Cited by 2
Nanotechnological Drug Delivery Strategies in Epilepsy
Esteruelas, G., Bonilla-Vidal, L., Ettcheto, M., Haro, I., Gomara, M. J., Souto, E. B., Espina, M., Camins, A., García, M. L., Sánchez‐López, E., et al. (2023) · Springer eBooks · doi:10.1007/978-981-99-6807-7_14 · Cited by 1
Nanotechnology for Cerebral Aneurysm Treatment
Aditya, T., Posada, V. M., & Allain, J. P. (2024) · Springer eBooks · doi:10.1007/978-3-030-80662-0_18 · Cited by 3
Ecotoxicity Potential of Carbon and Metal Nanoparticles: Delving into the Darker Realm
Ghosh, B., Sarkar, S., & Paul, S. (2025) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-97-9922-0_26 · Cited by 1
The Strategies of Nanomaterials for Drug Delivery and Release
Wang, J., Huang, Q., & Liang, X. (2019) · Springer eBooks · doi:10.1007/978-981-13-8731-9_3 · Cited by 1
Rauf, M. A., Tatiparti, K., & Iyer, A. K. (2021) · Springer eBooks · doi:10.1007/978-981-16-4558-7_12 · Cited by 1
Emara, E. M., El‐Sayyad, H. I., Mowafy, A. M., & Elghaweet, H. A. (2023) · Egyptian Journal of Basic and Applied Sciences · doi:10.1080/2314808x.2023.2192582 · Cited by 1
“Nanomedicine is used to treat cerebral ischemia by active targeting (using targeting ligands) or passive targeting (using enhanced permeability and retention effect) due to an increase in the number of patients with neurodegenerative diseases [15].”
BackgroundNanomaterial-based approach in stroke
Ghosh, B., Datta, A., Sarmah, D., Rana, N., Chaudhary, A., Borah, A., & Bhattacharya, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00082-8 · Cited by 1
Liposomes as a Potential Carrier for Brain Delivery
Thakur, A. S., Vishwas, S., Badwaik, H., Paul, S. D., Sakure, K., & Nakhate, K. T. (2024) · Springer eBooks · doi:10.1007/978-981-97-2859-6_6 · Cited by 2
Current insight on anti-tumor effect of natural products
Hao, T., Liang, R., Chen, X., Zhang, X., Lian, Y., & Chen, L. (2016) · European Journal of BioMedical Research · doi:10.18088/ejbmr.2.1.2016.pp18-20
“Natural bioactive products are promising in cancer therapy but the concern is that their effects on inhibiting tumor cells’ growth and inducing cell apoptosis are mainly based on in vitro experiments (22,23).”
BackgroundMethodResearch progress on hypoglycemic active components in natural products
Chen, X., Chen, L., Liang, R., Hao, T., Zhang, X., & Lian, Y. (2016) · European Journal of BioMedical Research · doi:10.18088/ejbmr.2.1.2016.pp21-26
Anti-obesity effect of traditional Chinese medicine and natural products
Chen, L., Lian, Y., Lyu, J., Tan, T., & Wang, Y. (2016) · European Journal of BioMedical Research · doi:10.18088/ejbmr.2.1.2016.pp41-45
Novel strategies to improve delivery performances
Mauri, E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817838-6.00003-6
Potential of nanoparticles as novel therapeutics against Alzheimer’s disease
Ujjwal, R. R., Maharana, S. K., Handa, M., & Krishna, S. T. V. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85544-0.00015-0
Nanodelivery of Polyphenols as Nutraceuticals for Neurological Disorders
Paul, A., Gogoi, M., & Zaman, K. (2023) · Wiley eBooks · doi:10.1002/9781394188864.ch12
Deciphering the Role of Nanomedicines for the Treatment of Ischemic Stroke
Ahmad, F., Karan, A., Sharma, N. S., Sundar, V., Jayaraj, R. L., & Abiha, U. (2023) · Springer eBooks · doi:10.1007/978-981-99-9510-3_9
Metadata
- Authors
- Zhang, T.-T., Li, W., Meng, G., Wang, P., & Liao, W.
- Affiliations
- Department of Food Science and Technology
- IHRC
- Tongde Hospital of Zhejiang Province (CN)
- North Carolina Agricultural and Technical State University (US)
- South China University of Technology (CN)
- Corresponding author
- Liao, Wenzhen
- Venue
- Biomaterials Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2016
- Volume
- 4
- Issue
- 2
- Pages
- 219-229
- ISSN
- 2047-4830 (ISSN-L)
- 2047-4849
- OpenAlex
- W2190350005
- Cited by
- 308
- References
- 115
- Citations by year
- 2026: 6 · 2025: 35 · 2024: 40 · 2023: 31 · 2022: 33 · 2021: 33 · 2020: 41 · 2019: 21 · 2018: 23 · 2017: 24 · 2016: 21
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biomaterials Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- blood-brain barrier, nanoparticles, brain drug delivery, central nervous system disorders, nanomedicine
- MeSH terms
- Biological Transport, Blood-Brain Barrier, Brain, Central Nervous System, Central Nervous System Diseases, Humans, Drug Delivery Systems, Nanotechnology, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.